keepontruckin
Senior Member
- Messages
- 204
https://www.sciencedaily.com/releases/2023/03/230308084337.htm
"Next, we are going to look at studying the use of Foralumab in long COVID, larger studies of multiple sclerosis, and other diseases such as Alzheimer's disease."
Also published today
https://www.sciencedaily.com/releases/2023/03/230308112118.htm March 8, 2023
Potential new therapeutic target for inflammatory diseases such as lupus and sepsis
Scientists have made an important breakthrough in understanding what goes wrong in our bodies during the progression of inflammatory diseases and -- in doing so -- unearthed a potential new therapeutic target. The scientists have found that an enzyme called fumarate hydratase is repressed in macrophages, a frontline inflammatory cell type implicated in a range of diseases including lupus, arthritis, sepsis and COVID-19.
"Next, we are going to look at studying the use of Foralumab in long COVID, larger studies of multiple sclerosis, and other diseases such as Alzheimer's disease."
Also published today
https://www.sciencedaily.com/releases/2023/03/230308112118.htm March 8, 2023
Potential new therapeutic target for inflammatory diseases such as lupus and sepsis
Scientists have made an important breakthrough in understanding what goes wrong in our bodies during the progression of inflammatory diseases and -- in doing so -- unearthed a potential new therapeutic target. The scientists have found that an enzyme called fumarate hydratase is repressed in macrophages, a frontline inflammatory cell type implicated in a range of diseases including lupus, arthritis, sepsis and COVID-19.
Last edited: